Inhibition of SARS-CoV gene expression by adenovirus-delivered small hairpin RNA

Intervirology

Volumn 50, Issue 2, 2007, Pages 63-70

  Zhang, Xue ^a   Wu, Kailang ^a   Yue, Xin ^a   Zhu, Ying ^a   Wu, Jianguo ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Adenovirus; Envelope protein; Nucleocapsid protein; SARS CoV; Small hairpin RNA

Indexed keywords

ADENOVIRUS VECTOR; ENVELOPE PROTEIN; NUCLEOCAPSID PROTEIN; SHORT HAIRPIN RNA;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL LINE; CELL TYPE; DNA TRANSFECTION; ENZYME ASSAY; GENE CONSTRUCT; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE IDENTIFICATION; GENE REPRESSION; GENE TARGETING; GENETIC SCREENING; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARS CORONAVIRUS; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; CELL LINE; CERCOPITHECUS AETHIOPS; GENE EXPRESSION; GENES, REPORTER; GENETIC VECTORS; HUMANS; LUCIFERASES; NUCLEOCAPSID PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, ANTISENSE; RNA, VIRAL; SARS VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS; VIRUS REPLICATION;

ADENOVIRIDAE; CORONAVIRUS; MAMMALIA; SARS CORONAVIRUS;

EID: 33846971224     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097391     Document Type: Article

References (36)

1. Drosten C, Gunther S, Preiser W, Werf S, Van der Brodt HR, Becker S, Rabenau H: Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-1976.
2. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY: Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;361:1319-1325.
3. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS: Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003;361:1767-1772.
4. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C: A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-1966.
5. Rota PA, Oberste MS, Bellini WJ: Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300:1394-1399.
6. Marra MA, Jones SJM, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YSN: The genome sequence of the SARS-associated coronavirus. Science 2003;300:1399-1404.
7. Fields BN, Knipe DM, Howley PM: Fields Virology, ed 3. Philadelphia, Lippincott Williams & Wilkins, 2001, pp 1443-1485.
8. Macneughton MR, Davies HA: Ribonucleoprotein-like structures from coronavirus particles. J Gen Virol 1978;39:545-549.
9. Lai MMC, Cavanagh D: The molecular biology of coronaviruses. Adv Virus Res 1997;48:1-100.
10. Wang Y, Zhang X: The nucleocapsid protein of coronavirus mouse hepatitis virus interacts with the cellular heterogeneous nuclear ribonucleoprotein A1 in vitro and in vivo. Virology 1999;265:96-109.
11. He R, Leeson A, Andonov A, Li Y, Bastien N, Cao J, Osiowy C, Dobie F, Cutts T, Ballantine M, Li X: Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein. Biochem Biophys Res Commun 2003;311:870-876.
12. Myers TM, Pieters A, Moyer SA: A highly conserved region of the Sendai virus nucleocapsid protein contributes to the NP-NP binding domain. Virology 1997;229:322-335.
13. Alfadhli A, Steel E, Finlay L, Bachinger HP, Barklis E: Hantavirus nucleocapsid protein coiled-coil domains. J Biol Chem 2002;277:27103-27108.
14. Bos EC, Luytjes W, van der Meulen HV, Koerten HK, Spaan WJ: The production of recombinant infectious DI particles of a murine coronavirus in the absence of helper virus. Virology 1996;218:52-60.
15. Vennema H, Godeke GJ, Rossen JW, Voorhout WF, Horzinek MC, Opstelten DJ, Rottier PJ: Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J 1996;15:2020-2028.
16. Fire A: RNA-triggered gene silencing. Trends Genet 1999;15:358-363.
17. Marx J: Interfering with gene expression. Science 2000;288:1370-1372.
18. Hutvagner G, Zamore PK: RNAi: Nature abhors a double-strand. Curr Opin Genet Dev 2002;12:225-232.
19. Sharp PA: RNA interference 2001. Genes Dev 2001;15:485-490.
20. Coburn GA, Cullen BR: Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol 2002;76:9225-9231.
21. Jacque JM, Triques K, Stevensom M: Modulation of HIV-1 replication by RNA interference. Nature 2002;418:435-538.
22. Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsami A, Salvaterra P: Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 2002;20:500-505.
23. Hu WY, Myers CP, Kilzer JM, Pfaff SL, Bushman FD: Inhibition of retroviral pathogenesis by RNA interference. Curr Biol 2002;12:1301-1311.
24. Adelman ZN, Sanchez-Vargas I, Travanty EA, Carlson JO, Beaty BJ, Blair CD, Olson KE: RNA silencing of dengue virus type 2 replication in transformed C6/36 mosquito cells transcribing an inverted-repeat RNA derived from the virus genome. J Virol 2002;76:12925-12933.
25. Kapadia SB, Brideau-Andersen A, Chisari FV: Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci USA 2003;100:2014-2018.
26. Ge Q, McManus MT, Nguyen T, Shen CH, Sharp PA, Eisen HN, Chen J: RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci USA 2003;100:2718-2723.
27. Hamasaki K, Nakao K, Matsumoto K, Ichikawa T, Ishikawa H, Eguchi K: Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Lett 2003;543:51-54.
28. McCaffrey AP, Nakai H, Pandey K, Huang Z, Salazar FH, Xu H, Wieland SF, Paul CP, Good PD, Winer I, Engelke DR: Effective expression of small interfering RNA in human cells. Nat Biotechnol 2002;20:505-508.
29. Lu AL, Zhang HQ: Attenuation of SARS coronavirus by a short hairpin RNA expression plasmid targeting RNA-dependent RNA polymerase. Virology 2004;324:84-89.
30. Zhao P, Qin ZL: Small interfering RNA inhibits SARS-CoV nucleocapsid gene expression in cultured cells and mouse muscles. FEBS Lett 2005;579:2404-2410.
31. Raghuvir S, Tomar HM, Preet MC: Use of adeno-associated viral vector for delivery of small interfering RNA. Oncogene 2003;22:5712-5715.
32. Wu KL, Zhang X: Inhibition of hepatitis B virus gene expression by single and dual small interfering RNA treatment. Virus Res 2005;112:100-107.
33. Gao W, Tamin A, Gambotto A: Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet 2003;362:1895-1896.
34. Sui J, Li W, Marasco WA: Potent neutralization of severe acute respiratory syndrome coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci USA 2004;101:2536-2541.
35. Moriguchi H, Sato C: Treatment of SARS with human interferons. Lancet 2003;362:1159.
36. Haagmans BL, Kuiken T, Osterhaus AD: Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat Med 2004;10:290-293.